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The History 
1995 was an exciting year for the field of apoptosis. In 
that year, Nicholson et alo purified a protease that 
cleaves poly (ADP-ribose) polymerase (PARP), a protein 
that was known to be cleaved during apoptosis (Nichol- 
son et al., 1995; Kaufmann et al., 1993). The cDNA en- 
coding this protease, Apopaln, turned out to be the same 
as CPP32, a cDNA that was cloned in the previous year 
by Emad Alnemri's group through EST database mining 
based the conserved sequences between the C. elegans 
apoptotic protease Ced3 and the mammalian interleu- 
kin-l(~ converting enzyme (Femandes-Alnemri et al., 
1994). The purification of Apopain unified the biochemis- 
try of mammalian apoptosis with the genetics that had 
been established in C. elegans. But the crucial question 
remained: "What activates Apopain?" 
Wang remembers Alnemri's paper vividly because it 
caused quite a stir in the laboratory of Joe Goldstein 
and Mike Brown. As a postdoctoral fellow in their lab, 
Wang was searching for a sterol-regulated protease that 
cleaves a pair of membrane bound transcriptional fac- 
tors, SREBP-1 and -2. He used in vitro translated, 3~S- 
labeled SREBP-2 as a substrate and incubated it with 
cell extracts from large-scale cultures of HeLa cells. 
After several months of fruitless searching, he became 
rather desperate and somewhat sloppy. One Friday, he 
left some cytosolic extracts in a 4°C refrigerator for the 
entire weekend instead of freezing them at -80°C. On 
the following Monday, to his surprise he found an 
SREBP-2 cleavage activity (Sca) that was not there the 
previous Friday. After a brainstorming session with 
Brown and Goldstein, they postulated that there must 
be a latent activity that was slowly activated in the refrig- 
erator. By raising the incubation temperature to 37°C, 
Wang reproduced the activation in only two hours. 
In a few months, Wang and a graduate student, Jih- 
tung Pai, purified this SREBP cleavage activity using 
classical biochemical fractionation methods. The se- 
quence of the purified enzyme revealed a novel protein. 
As they were in the process of cloning this protein, the 
paper describing the cloning of CPP32 appeared in JBC 
and to their astonishment the protein sequence of the 
SREBP cleavage enzyme was the same as CPP32. Un- 
knowingly, they had been following the same path as 
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Nicholson, since SREBP-2, like PARP, proved to be a 
substrate for CPP32/Apopain (Wang et al., 1995). 
CPP32/Apopain/Sca, now universally known as casp- 
ase-3, is only activated in cells during apoptosis and (to 
Brown and Goldstein's disappointment) it was not the 
sterol-regulated protease that cleaves SREBP and regu- 
lates sterol homeostasis. Nonetheless, Wang remained 
intrigued about how caspase-3 becomes activated, At 
this point, Wang left the Brown/Goldstein laboratory and 
moved to Emory University where he started his own 
laboratory as an Assistant Professor. Wang decided to 
continue his studies of CPP32, focusing now on its acti- 
vation in apoptosis. He first attempted to accelerate the 
activation reaction in vitro by adding small molecules 
including nucleotides and kinase or phosphatase inhibi- 
tors. Together with his first graduate student, Xuesong 
Liu, he found that ATP accelerates caspase-3 activation. 
When they compared the effect of ATP versus other 
nucleotides, they found, surprisingly, that dATP is 10- 
fold more active than ATP. By adding dATP to cytosolic 
extracts from nonapoptotic HeLa cells, they reduced 
the complicated process of apoptosis activation to a 
simple in vitro assay for caspase-3 activation. Using this 
assay and classical fractionation methods, they isolated 
in order the following three proteins that are necessary 
and sufficient for this reaction: cytochrome c, Apaf-1, 
and procaspase-9. 
The Discovery 
The paper by Li et al., 1997 that was chosen for this 
commemorative issue, was the third paper from Wang's 
laboratory that described our biochemical approach to 
apoptosis. This paper also combined our biochemical 
studies with the molecular biological work from Emad 
AInemri's group. The first paper identified cytochrome 
c as a necessary component for caspase-3 activation 
in vitro and made the observation that cytochrome c is 
released from mitochondria to cytosol during apoptosis 
(Liu et al., 1996). For obvious reasons, this paper drew 
heavy criticism and frank disbelief or quite some time. 
The vital function of cytochrome c in the electron trans- 
fer chain was well accepted and difficult to reconcile 
with a proapoptotic activity. After all, in our first paper, 
we were unable to provide any mechanistic data ex- 
plaining how cytochrome c activates caspase-3. At this 
point we left Emory and returned to Dallas where Wang 
became the first recruit to a new department of Bio- 
chemistry that was being created by Steve McKnight. 
In Dallas we continued our work on apoptosis activa- 
tion. The work led to our second paper, in which we 
purified a second factor necessary for caspase-3 activa- 
tion and named it Apaf-1, which was subsequently 
cloned by Dr. Hua Zou. Remarkably, the sequence of 
Apaf-1 revealed partial homology to the C. elegans pro- 
apoptotic protein Ced4 (Zou et al., 1997). For several 
years, the mammalian Ced4 homolog had defied identifi- 
cation. It remained the last missing piece of an apoptotic 
pathway that was otherwise conserved from humans 
to worms. Understandably, Apaf-1 received a much warmer 
welcome, than cytochrome c. Apaf-1 is about twice the 
size of Ced4. The N-terminal region of Apaf-1 resembles 
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Ced4 and it was proposed to function as the caspase 
recruitment domain (CARD). The C-terminal extension of 
Apaf-1 contains multiple WD-40 repeats that are missing 
in Ced4. The finding that Apaf-1 binds cytochrome c 
helped clarifying the role of cytochrome c as an initiator 
of apoptosis. 
By now our work was beginning to receive some posi- 
tive attention. Our third paper, which described the 
mechanism by which cytochrome c and Apaf-1 activate 
caspase-3, established that a third protein was required 
for in vitro caspase-3 activation (Li et al., 1997). This 
protein turned out to be procaspase-9, a "CARD-car- 
rying" caspase. In this paper, we showed that caspase-9 
initiates the caspase cascade by cleaving procaspase-3. 
Procaspase-9 is converted to the active caspase-9 after 
the CARD domains of procaspase-9 and Apaf-1 interact. 
The CARD-CARD interaction between Apaf-1 and pro- 
caspase-9 does not happen in the absence of cyto- 
chrome c and ATP/dATP. In the presence of ATP/dATP, 
cytochrome c binding to Apaf-1 induces a conformation 
change of Apaf-1 that exposes its CARD so that it can 
recruit procaspase-9. An active-site mutant form of pro- 
caspase-9 suppressed the cytochrome c-initiated casp- 
ase-3 activation in a dominant-negative fashion, pre- 
sumably by keeping the wild-type procaspase-9 from 
binding Apaf-1 CARD. To us, the most remarkable as- 
pect of this whole story was the occurrence of the entire 
cytochrome C/Apaf-1/procaspase-9/procaspase-3 ac- 
tivation sequence in the refrigerator over the weekend 
in the Brown-Goldstein laboratory. Had these reactions 
not occurred, Wang would never have been introduced 
to apoptosis. From such improbable events, scientific 
careers do arise. 
The Follow-Up 
Caspase-9 proved to be unique in many ways. Rodri- 
guez and Lazebnik found that unlike other caspases, 
free caspase-9 has minimal activity compared to Apaf-1 
bound caspase-9 (Rodriguez and Lazebnik, 1999). In 
another surprising finding made by Guy Salvesen and 
colleagues, procaspase-9 can be activated after binding 
to Apaf-1 even without proteolytic leavage (Stennicke 
et al., 1999). All other known caspases are activated 
only after proteolytic leavage. 
How is procaspase-9 activated when complexed with 
Apaf-1 ? We subsequently showed that Apaf-1 normally 
exists as a monomer, but in the presence of cytochrome 
c and ATP/dATP, Apaf-1 forms a much larger complex, 
termed "apoptosome" (Zou et al., 1999). After cyto- 
chrome c binds to Apaf-1, Apaf-1 undergoes a confor- 
mational change that exposes a previously hidden nu- 
cleotide binding region that becomes accessible to free 
nucleotide. When nucleotide binds to Apaf-1, it drives 
the Apaf-1/cytochrome c complex to oligomerize into 
the apoptosome (Jiang and Wang, 2001). By using cryo- 
EM technology, Chris Akey's group recently showed 
that the apoptosome exhibits a symmetrical wheel-like 
structure composed of seven molecules each of Apaf-1 
and cytochrome c. The exposed N-terminal CARD do- 
mains of Apaf-1 form a central hub region, and the 
C-terminal WD40 repeats are extended to form the cyto- 
chrome c binding spikes (Acehan et al., 2002). The cryo- 
EM structures containing procaspase-9 suggested that 
the CARD domains in the central hub effectively create 
an enriched local concentration of procaspase-9. The 
CARD domain interaction between Apaf-1 and casp- 
ase-9 may induce the enzyme to adopt a fully extended, 
active conformation that permits the formation of active 
dimer enzyme and autocalytic cleavage (Acehan et 
al., 2002). 
In as much as activated caspase-9 can be fatal, cells 
go to extraordinary lengths to prevent unintended casp- 
ase-9 activation. Even after cytochrome c is released, 
the cell uses XlAP (and possibly other lAPs) as a second 
tier regulator to extinguish unintended caspase-9 acti- 
vation. XlAP is an antiapoptotic protein that binds to 
and inhibits the newly generated active N terminus of 
caspase-9 after autocatalysis (Shiozaki et al., 2003). This 
inhibition is relieved by the release of lAP-antagonizing 
proteins from mitochondria including Smac/Diablo and 
Omi/HtrA2 (reviewed by Vaux and Silke, 2003). The dual 
requirement for cytochrome c and either Smac/Diablo 
or Omi/HtrA2 acts like a coincidence circuit. Caspase-9 
is activated only when both limbs of this circuit function 
simultaneously. 
Apoptosis and Cancer 
In order to become malignant, cancer cells must find a 
way to evade the apoptotic cascade, which otherwise 
would result in their elimination. This evasion also ren- 
ders tumors resistant o apoptosis-inducing cytotoxic 
agents, including ionizing radiation. For these reasons 
many laboratories are searching for small molecules that 
can restore the blocked apoptosis in cancer cells. In one 
such search, Rosenberg et al. at Abbott Laboratories 
carried out a high throughput screen for compounds 
that activate caspase-3 in HeLa cell extracts (Jiang et 
al., 2003). This screen revealed that ~-(trichloromethyl)- 
4-pyridineethanol promotes apoptosome formation. 
While studying how this chemical activates caspase-3, 
Dr. Xuejun Jiang in our lab found two other proteins that 
regulate apoptosome formation: prothymosin-~ and 
PHAP proteins. After apoptosome formation, caspase-9 
recruitment and activation is enhanced by PHAP pro- 
teins, which are thereby tumor suppressors. Prothy- 
mosin-~ has the opposite effect: it inhibits apoptosome 
action, and therefore it is an oncoprotein. The small mole- 
cule ~-(trichloromethyl)-4-pyridineethanol ctivates apo- 
ptosome formation by blocking the inhibitory effect of 
prothymosin-c~ (Jiang et al., 2003). Compounds that rep- 
licate this activity are potential anticancer agents. 
The Remaining Questions 
The most unexpected feature of caspase-9 activation 
pathway was that it is triggered by cytochrome c, a 
mitochondrial protein that is released to the cytosol so 
that it can bind Apaf-1, a cytosolic protein. The mito- 
chondrial connection had not been made in the genetic 
experiments in invertebrates. Although Apaf-1 and 
caspase-9 have clear homologs in invertebrates like 
worms and fruit flies, we still do not know how these 
proteins are activated during apoptosis in these organ- 
isms. Recent work from Hermann Steller's laboratory 
indicates that a form of cytochrome c, cytochrome 
c-d, is critical for activating caspases during the differ- 
entiation of fly sperm, a process that shares many fea- 
tures with apoptosis (Arama et al., 2003). Future bio- 
chemical studies using materials from these organisms 
should dispel many mysteries about the evolutionary 
origin of the mitochondrial role in apoptosis. 
The role of the mitochondrial apoptosis pathway in 
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postnatal  t issue homeostas is  can be studied in mam-  
mals by t issue-specif ic knockout  of the genes involved. 
Germ-line knockout  of Apaf-1, caspase-9, and caspase-3 
revealed only their  roles in neural deve lopment  since 
mice without these genes die pre and perinatally of neural 
dysfunction (Kuida et al., 1996, 1998; Yoshida et al., 1998), 
A l though purif ied Apaf-1, procaspase-9,  procas-  
pase-3, and cytochrome c are suff icient to reconst i tute 
the caspase-3 act ivat ion cascade in vitro, we  a l ready 
know that other  regulatory proteins contr ibute in vivo. 
Prothymosin-~ and PHAP proteins are two  such proteins 
that  have been identif ied recently. These two  proteins 
need addit ional  mediators.  Hopeful ly,  the b iochemical  
identi f icat ion of new apoptos is  regulators will lead to 
more  tumor  suppressors or oncogenic  proteins that can 
be targets of drug deve lopments .  
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Summary 
We have cloned the C. elegans cell death gene ced-3. 
A ced-3 transcript is most abundant during embryo- 
genesis, the stage during which most programmed cell 
deaths occur. The predicted CED-3 protein shows sim- 
ilarity to human and murine interleukin-1 t~-converting 
enzyme and to the product of the mouse nedd-2 gene, 
which is expressed in the embryonic brain. The se- 
quences of 12 ced-3 mutations as well as the se- 
quences of ced-3 genes from two related nematode 
species identify sites of potential functional impor- 
tance. We propose that the CED-3 protein acts as a 
cysteine protease in the initiation of programmed cell 
death in C. elegans and that cysteine proteases also 
function in programmed cell death in mammals. 
Introduction 
Cell death occurs as a normal aspect of animal devel- 
opment as well as in tissue homeostasis and aging 
(Glucksmann, 1950; Ellis et al., 1991a). Naturally oc- 
curring or programmed cell death can act to regulate cell 
number, to facilitate morphogenesis, to remove harmful 
or otherwise abnormal cells, and to eliminate cells that 
have already performed their functions. In many cases, 
gene expression within dying cells is thought o be re- 
quired for these cells to die, since the cell death process 
can be blocked by inhibitors of RNA and protein synthesis 
(Stanisic et al., 1978; Cohen and Duke, 1984; Martin et 
al., 1988). 
During the development of the nematode Caenorhab- 
ditis elegans, 131 cells undergo programmed cell death 
(Sulston and Horvitz, 1977; Sulston et al., 1983). Fourteen 
genes have been identified that function in different steps 
of the genetic pathway of programmed cell death in C. 
elegans (Hedgecock et al., 1983; Ellis and Horvitz, 1986, 
Present address: Neuroimmunology Laboratory, Montreal Neurologi- 
cal Institute, Montreal, Quebec H3A 2134, Canada. 
~lPresent address: Department of Biology, Emory University, Atlanta, 
Georgia 30322. 
1991; Ellis et al., 1991 b; Hengartner et al., 1992; reviewed 
by Ellis et al., 1991a). Two of these genes, ced-3 and ced-4, 
play essential roles in either the initiation or execution of 
the cell death program, since recessive mutations in these 
genes prevent almost all of the cell deaths that normally 
occur during C. elegans development. Genetic mosaic 
analysis indicates that ced-3 and ced-4 most likely function 
within cells that die or within their close relatives to cause 
cell death (Yuan and Horvitz, 1990). The ced-4 gene en- 
codes a novel protein that is expressed primarily during 
embryogenesis, the period during which most pro- 
grammed cell deaths occur (Yuan and Horvitz, 1992). 
To understand how the ced-3 gene acts to cause cell 
death, we have cloned this gene. As deduced from the 
sequence of a ced-3 cDNA clone, the CED-3 protein is 
503 amino acids in length and contains a serine-rich mid- 
dle region of about 100 amino acids. We compared the 
sequences of the CED-3 protein of C. elegans with the 
inferred CED-3 protein sequences from the related nema- 
tode species C. briggsae and C. vulgaris. This comparison 
revealed that the carboxy-terminal portions of these pro- 
teins are most conserved. The non-serine-rich portions 
of the CED-3 protein are similar to human interleukin-1 
(IL-1 I~)-converting enzyme (ICE), a cysteine protease that 
can cleave the inactive 31 kd precursor of IL-113 to generate 
the active cytokine (Cerretti et al., 1992; Thomberry et al., 
1992). In addition, the carboxy-terminal portions of both 
the CED-3 and ICE proteins are similar to the mouse 
Nedd-2 protein, which is encoded by a messenger RNA 
(mRNA) expressed during mouse embryonic brain devel- 
opment and is down-regulated in adult brain (Kumar et 
al., 1992). We suggest that CED-3 acts as a cysteine prote- 
ase in controlling the onset of programmed cell death in C. 
elegans and that members of the ced-3/ICE/nedd-2 gene 
family might function in programmed cell death in verte- 
brates. 
Results 
ced-3 Is Not Essential for Viability 
All previously described ced-3 alleles were isolated in 
screens designed to detect viable mutants in which pro- 
grammed cell death did not occur (Ellis and Horvltz, 1986). 
Such screens might systematically have missed classes 
of ced-3 mutations that result in inviability. Since animals 
of the genotype ced-3/deficiency are viable (Ellis and Hor- 
vitz, 1986), we designed a screen that would allow us to 
isolate recessive lethal alleles of ced-3, if such alleles 
could exist (see Experimental Procedures). We obtained 
four new ced-3 alleles (n 1163, n 1164, n 1165, and n 1286) 
in this way. All four of these mutants are viable as homozy- 
gotes. These alleles were isolated at a frequency of about 
1 in 2500 mutagenized haploid genomes, approximately 
the frequency expected for the generation of loss-of- 
function mutations in an average C. elegans gene (Bren- 
ner, 1974; Meneely and Herman, 1979; Greenwald and 
Horvitz, 1980). 
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Summary 
We report here the purification of the third protein 
factor, Apaf-3, that participates in caspaee-3 activa- 
lion in vitro. Apaf-3 was identified as a member of the 
caspase family, caspase-9. Caspase-g and Apaf-I 
bind to each other via their respective NH2-terminal 
CED-3 homologous domains in the presence of cyto- 
chrome c and dATP, an event that leads to caspase-9 
activation. Activated caspase-9 in turn cleaves and 
activates caspase-3. Depletion of caspase-9 from 
S- 100 extracts diminished caspase-3 activation. Muta- 
tion of the active site of caspase-9 attenuated the 
activation of caspase-3 and cellular apoptotic re- 
sponse in vivo, indicating that caspase-9 is the most 
upstream member of the apoptotic protease cascade 
that is triggered by cytochrome c and dATP. 
Introduction 
Apoptosis is a morphologically and biochemically dis- 
tinct form of cell death carried out by a genetically deter- 
mined cell suicide program (Kerr et ai., 1972; reviewed 
by Horvitz et al., 1994; Jacobson et al., 1997). Several 
apoptosis-regulating enes identified in Caenorhabditis 
elegans have counterparts in humans, demonstrating 
that the basic mechanism of apoptosis is evolutionarily 
conserved (Vaux, 1997). 
Three genes, ced-3, ced-4, and ced-9, encode the 
general apoptotic program in C. elegans (Horvitz et al., 
1994). ced-9 negatively regulates apoptosis while ced-4 
and ced-3 are required to execute the apoptotic pro- 
gram (Yuan and Horvitz, 1990; Hengartner et al., 1992). 
The bcl-2 family of proteins are mammalian relatives of 
CED-9 (Vaux et al., 1992; Hengartner and Horvitz, 1994). 
Bcl-2 is an integral membrane protein located mainly 
on the outer membrane of mitochondria (Monaghan et 
al., 1992; Krajewski et al., 1993; de Jong et al., 1994). 
CED-4 is homologous to the recently identified human 
protein, Apaf-1, which participates in the activation of 
the mammalian CED-3 homolog, caspase-3 (Yuan and 
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al., 1994; Nicholson et al., 1995; Tewari et al., 1995; Xue 
et al., 1996; Zou et al., 1997). 
ced-4 has been determined genetically to function 
downstream of ced-9 but upstream of ced-3 (Shaham 
and Horvitz, 1996a, 1996b). Likewise, Apaf-1 functions 
downstream of bcl-2 but upstream of caspase-3 (Zou 
et al., 1997). Bcl-2 may function upstream of Apaf-1 by 
regulating the release of cytochrome c from mitochon- 
dria. Cytochrome c is a required cofactor for Apaf-1 
function (Liu et al., 1996b; Zou et al., 1997). Consistent 
with this hypothesis, overexpression of bcl-2, or its close 
family member bcI-XI, blocks the release of cytochrome 
c from mitochondria, which otherwise occurs when cells 
are signaled to undergo apoptosis (Kharbanda et al., 
1997; Kim et al., 1997; Kluck et al., 1997; Yang et al., 
1997). In addition, the bcl-2 family of proteins might also 
directly interact with Apaf-1 in a fashion similar to the 
interaction between CED-4 and CED-9 (Chinnaiyan et 
al., 1997; Seshagiri and Miller, 1997; Spector et al., 1997; 
Wu et al., 1997). 
Various stimuli of apoptosis lead to the activation of a 
family of cysteine proteases with specificity for aspartic 
acid residues, referred to as caspases (Alnemri et al., 
1996). The activated caspases cleave a variety of target 
proteins, thereby disabling important cellular processes 
and breaking down structural components of the cell 
(Nicholson and Thornberry, 1997). The targets of such 
cleavage events include poly(ADP-dbose) polymerase 
(Nicholson et al., 1995; Tewari et al., 1995), sterol regula- 
tory element binding proteins (Wang et al., 1996), retino- 
blastoma (RB) protein (An et al., 1996; Janicke et al., 
1996), nuclear lamins (Lazebnik et al., 1995; Orth et al., 
1996; Takahashi et al., 1996), DNA-dependent protein 
kinase (Casciola-Rosen et al., 1996; Song et al., 1996), 
U1 70-K protein (Caciola-Rosen et al. 1996), and the 
large subunit of the DNA replication complex C (Ubeda 
and Habener, 1997). In addition, activated caspasas lead 
to cleavage of the 45 kDa subunit of DNA fragmentation 
factor (DFF-45). This cleavage activates a pathway lead- 
ing to fragmentation of genomic DNA into nucleosomal 
fragments, a hallmark of apoptosis (Liu et al., 1997). 
Caspase-3 is activated by two sequential proteolytic 
events that cleave the 32 kDa precursor at aspartic acid 
residues to generate an active heterodimer of 20 kDa 
and 12 kDa subunits (Nicholson et al., 1995). The activa- 
tion might be autocatalytic, or it might occur via a cas- 
pase cascade, similar to the serine protease cascade 
in the blood clotting process. Such a cascade might 
amplify apoptotic signals leading to fast and irreversible 
apoptosis. The active caspases are promiscuous in 
cleaving other caspases, making it difficult to identify 
the initial triggering event in caspase activation (Tewari 
et al., 1995; I_iu et al., 1996a; Muzio et al., 1996; Sriniva- 
sula et al., 1996a; Wang et al., 1996). 
We have recently established an in vitro system in 
which caspase-3 is activated by the addition of dATP 
to cytosol from normally growing cells (Liu et al., 1996b). 
This system enabled us to study the triggering events 
in caspase-3 activation. Fractionation of HeLa cytosol 
